• Facebook
  • Twitter
  • Wiki

University of Mons-Hainaut

Recent publications include

▪       Saussez S, Decaesteker C, Chevalier D, Kaltner H, Andre S,  Wacrenier A, Toubeau G, Gabius Hj, Kiss R. The Determination of Circulating Levels of Galectin-1 and -3 in HNSCC Patients Could Be Used to Monitor Tumor Progression and/or Responses to Therapy. Oral Oncology, 44;86-93, 2008 (IF:2.6).

▪       Saussez S, Decaestecker C, Lorfevre F, Chevalier D, Mortuaire G, Kaltner H, Andre S, Toubeau G, Gabius HJ, Leroy X.  Increased Expression and Altered Intracellular Distribution of Adhesion/Growth-regulatory Lectins Galectins-1 and -7 during Tumour Progression in Hypopharyngeal and Laryngeal Squamous Cell Carcinomas. Histopathology, 52; 483-493, 2008 (IF: 4.2).

▪       Saussez S, Glinoer D, Chantrain G, Pattou F, Carnaille B, Andre S, Gabius HJ, Laurent G. Serum galectin-1 and galectin-3 levels in benign and malignant thyroid nodular disease. Thyroid, 18:705-712 (IF: 2.1).

▪       Saussez S, Cucu D, Decaestecker C, Chevalier D, Kaltner H, André S,  Wacrenier A, Toubeau G, Camby I, Gabius HJ, Kiss R. Galectin-7 (p53-Induced Gene-1): A New Prognostic Predictor of Recurrence and Survival in Stage IV Hypopharyngeal Cancer.  Annals of Surgical Oncology, 13:999-1009, 2006 (IF: 3.4).

▪       Saussez S, Marchant H, Nagy N, Decaestecker C, Hassid S, Jortay A, Gabius  H-J, Danguy A, Salmon I, Kiss R.  Quantitative glycohistochemistry defines new prognostic markers in cancers of the oral cavity. Cancer 82: 252-260, 1998 (IF:4.6).